Agenda of the CHMP meeting 21-24 July 2025

Thirteenth Nitrosamine Implementation Oversight Group (NIOG) meeting, European Medicines Agency, Amsterdam, the Netherlands, 7 May 2025

Highlights from the 13th meeting of the Nitrosamine Implementation Oversight Group (NIOG)

30th anniversary scientific conference highlights

Human medicines European public assessment report (EPAR): Apremilast Accord, apremilast, Date of authorisation: 19/04/2024, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Ztalmy, ganaxolone, Date of authorisation: 26/07/2023, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR): Lazcluze, lazertinib, Date of authorisation: 20/01/2025, Revision: 1, Status: Authorised

PMS data matrix - Cross-platforms

European Medicines Agency Write PMS API implementation Guide (zip)

European Medicines Agency Write PMS API implementation Guide